Lichen Planopilaris & Frontal Fibrosing Alopecia Treatment in NYC
LPP and FFA can permanently damage hair follicles. The first question is not simply how much hair has been lost, but whether inflammation is still active today.
These related immune-mediated forms of cicatricial alopecia may require careful pattern recognition, trichoscopy and, in selected cases, scalp biopsy.
Inflammation Can Lead to Permanent Follicular Loss.
Lichen planopilaris and frontal fibrosing alopecia belong to the lymphocytic spectrum of primary scarring alopecia.
Inflammation develops around the follicular unit and can progressively damage structures required for continued hair growth.
Once a follicle has been completely destroyed and replaced by scar tissue, treatment cannot simply recreate it.
The Distribution Often Gives the First Clue.
These conditions overlap biologically, but their visible patterns can be quite different.
Recognizing the distribution helps guide scalp examination, trichoscopy and decisions about further testing.
Lichen Planopilaris
LPP often presents with irregular or multifocal areas of scarring hair loss. Inflammation may be most visible around follicles at the active margin.
Frontal Fibrosing Alopecia
FFA characteristically causes recession of the frontal and temporal hairline and frequently affects the eyebrows.
Is Inflammation Still Damaging Follicles?
The amount of visible hair loss does not necessarily tell us how active the disease is today.
Active inflammatory areas and established scar may exist side by side.
Follicles Remain, but Inflammation Is Present.
The priority is identifying areas where treatment may still help protect follicular structures from further injury.
Follicular Structure Has Already Been Lost.
Fully scarred areas have limited potential for regrowth, even when surrounding inflammation is successfully controlled.
Diagnosis Comes Before the Treatment Plan.
LPP and FFA may overlap with other inflammatory and nonscarring forms of hair loss.
Evaluation considers distribution, follicular openings, perifollicular inflammation, eyebrow involvement and whether another hair-loss process may be present at the same time.
The Active Edge May Tell Us More Than the Scar.
When scalp biopsy is needed, where the sample is taken can matter.
A completely scarred area may mainly demonstrate the final structural damage. An active or transitional margin may reveal more about the inflammatory process that is still occurring.
Clinical examination and trichoscopy can help identify an informative site where follicles remain and inflammatory changes are still present.
Learn More About Scalp BiopsyIdentify Where Disease Appears Active
Determine where follicular inflammation meets established hair loss.
Refine the Biopsy Site
Perifollicular scale, erythema and remaining follicular openings may help identify a useful sampling area.
Examine the Follicular Injury
Microscopy may demonstrate lymphocytic inflammation, fibrosis and follicular destruction.
Match the Microscopy to the Patient
Histopathology is interpreted together with the clinical pattern, trichoscopy and disease course.
Control Active Disease Before More Follicles Scar.
There is no single treatment protocol for every patient.
Management depends on disease activity, extent, clinical pattern, medical context and coexisting hair loss.
Suppress Active Inflammation
Topical or intralesional corticosteroids and selected other local anti-inflammatory therapies may be used according to location and disease activity.
Escalate When Local Therapy Is Not Enough
Hydroxychloroquine, doxycycline and other systemic anti-inflammatory or immunomodulatory strategies may be considered when clinically appropriate.
Address the Hairline Pattern
In selected patients with FFA, 5-alpha-reductase inhibitors may form part of an individualized plan with appropriate counseling.
Treat Pattern Hair Loss Separately
Cicatricial alopecia can coexist with androgenetic alopecia. Minoxidil or other appropriate treatment may be added for the nonscarring component.
Document Change Over Time
Symptoms, clinical examination, standardized photography and trichoscopy may help determine whether disease is stabilizing.
Because cicatricial alopecia can reactivate and graft survival may be reduced, candidacy requires cautious individualized assessment.
Stabilization Is a Clinical Outcome.
With scarring hair loss, meaningful improvement is not always dramatic visible regrowth.
Scarring Hair Loss Requires Diagnostic Precision.
The challenge is not simply recognizing that hair has already been lost. It is determining whether inflammation remains active and which follicles may still be preserved.
Dr. Viktoryia Kazlouskaya is board-certified in dermatology and dermatopathology. This dual perspective is particularly relevant when clinical findings, trichoscopy and scalp biopsy need to be interpreted together.
The goal is a treatment strategy built around diagnosis and disease activity, rather than a standardized menu of hair-loss procedures.
LPP & FFA Care on the Upper East Side.
Physician-led evaluation for inflammatory and scarring hair loss in a private Manhattan practice.
Questions Patients Often Ask.
The central questions are whether inflammatory disease remains active and which follicles remain viable.
01 What is lichen planopilaris?
Lichen planopilaris is an inflammatory form of primary scarring alopecia that affects hair follicles, most commonly on the scalp. It can lead to permanent follicular loss.
02 What is frontal fibrosing alopecia?
Frontal fibrosing alopecia is a related lymphocytic scarring alopecia characterized by recession of the frontal and temporal hairline. Eyebrow loss is also common.
03 Is FFA the same as LPP?
FFA is closely related to LPP and is commonly considered part of the same disease spectrum, but its clinical distribution and some treatment considerations differ.
04 Can hair grow back after LPP or FFA?
Regrowth depends on whether the follicular structure remains viable. Follicles that have been completely destroyed and replaced by scar tissue cannot reliably produce new hair.
05 How can you tell if the disease is active?
Activity may be suggested by progression, perifollicular redness or scale, symptoms and trichoscopic findings. No single symptom alone reliably establishes activity.
06 Can LPP or FFA stop progressing?
These conditions can become clinically stable, either with treatment or during their natural course, but activity can also persist or recur. Long-term follow-up may therefore remain important.
07 Do I need a scalp biopsy?
Not every patient requires biopsy. It may be especially useful when the diagnosis is uncertain or when histopathology may influence treatment. When performed, selecting an informative biopsy site matters.
08 How are LPP and FFA treated?
Treatment is individualized. Local corticosteroids, intralesional corticosteroids and systemic anti-inflammatory or immunomodulatory medications may be considered depending on disease activity, extent and medical context.
09 Is minoxidil a treatment for LPP or FFA?
Minoxidil does not replace treatment of active inflammatory scarring alopecia. It may be useful in selected patients, particularly when androgenetic alopecia or another nonscarring component is present at the same time.
10 How long does it take to know if treatment is working?
Response is assessed over time rather than from a single visit. Symptoms, progression, scalp examination, standardized photography and trichoscopy may all contribute to determining whether disease is stabilizing.
11 Can hair transplantation be considered?
Hair transplantation may be considered in carefully selected patients after disease has become clinically stable. Because cicatricial alopecia can reactivate, candidacy requires cautious assessment.
Preserve Follicles Before More Are Lost.
A precise evaluation can help determine whether inflammatory disease remains active, whether the pattern fits LPP or FFA and what treatment strategy is appropriate.